SARS-CoV-2 infection in households with and without young children: Nationwide cohort study, Denmark, 27 February 2020 to 26 February 2021.
Journal
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
entrez:
12
8
2022
pubmed:
13
8
2022
medline:
16
8
2022
Statut:
ppublish
Résumé
BackgroundInfections with seasonally spreading coronaviruses are common among young children during winter months in the northern hemisphere; the immunological response lasts around a year. However, it is not clear if living with young children changes the risk of SARS-CoV-2 infection among adults.AimOur aim was to investigate the association between living in a household with younger children and the risk of SARS-CoV-2 infections and hospitalisation.MethodsIn a nationwide cohort study, we followed all adults in Denmark aged 18 to 60 years from 27 February 2020 to 26 February 2021. Hazard ratios of SARS-CoV-2 infection by number of 10 months to 5 year-old children in the household were estimated using Cox regression adjusted for adult age, sex and other potential confounders. In a sensitivity analysis, we investigated the effect of the children's age.ResultsAmong 450,007 adults living in households with young children, 19,555 were tested positive for SARS-CoV-2, while among 2,628,500 adults without young children in their household, 110,069 were tested positive for SARS-CoV-2 (adjusted hazard ratio (aHR) = 1.10; 95% confidence interval (CI): 1.08-1.12). Among adults with young children, 620 were hospitalised with SARS-CoV-2, while 4,002 adults without children were hospitalised with SARS-CoV-2 (aHR = 0.97; 95% CI: 0.88-1.08). Sensitivity analyses found that an increasing number of younger children substantially increased the risk of SARS-CoV-2 infection but not hospitalisation.ConclusionLiving in a household with young children was associated with a small increased risk of SARS-CoV-2 infection.
Identifiants
pubmed: 35959688
doi: 10.2807/1560-7917.ES.2022.27.32.2101096
pmc: PMC9373601
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
PLoS One. 2021 Dec 22;16(12):e0261665
pubmed: 34937060
Lancet Infect Dis. 2022 Feb;22(2):183-195
pubmed: 34756186
J Infect Dis. 2020 Jun 16;222(1):9-16
pubmed: 32246136
N Engl J Med. 2022 Apr 21;386(16):1532-1546
pubmed: 35249272
JAMA Netw Open. 2021 Aug 2;4(8):e2122240
pubmed: 34448865
J Infect Dis. 2021 Feb 13;223(3):362-369
pubmed: 33119738
BMJ. 2021 Mar 18;372:n628
pubmed: 33737413
JAMA Pediatr. 2021 Feb 1;175(2):143-156
pubmed: 32975552
Clin Epidemiol. 2015 Nov 17;7:449-90
pubmed: 26604824
J Clin Microbiol. 2008 Jul;46(7):2368-73
pubmed: 18495857
Acta Paediatr. 2020 Aug;109(8):1525-1530
pubmed: 32430964
Arch Dis Child. 2021 Dec;106(12):1212-1217
pubmed: 33737319
Euro Surveill. 2014 Jan 09;19(1):
pubmed: 24434175
Dan Med Bull. 2006 Nov;53(4):441-9
pubmed: 17150149
Am J Epidemiol. 2008 Feb 1;167(3):271-9
pubmed: 18000019
Lancet Child Adolesc Health. 2021 Oct;5(10):708-718
pubmed: 34358472
J Med Virol. 1979;3(4):313-20
pubmed: 113504
J Clin Virol. 2012 Feb;53(2):135-9
pubmed: 22188723